Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines
4 Dec 202304/12/23 at 09:442023-12-04 09:44:04 por 
Martín Pérez Comisso
| Categoría | Caso 3: Selección tecnológica |
|---|---|
| URL | https://www.frontiersin.org/articles/10.3389/fimmu.2022.840104/full#:~:text=live%20attenuated%20viruses.-,CYD%2DTDV%20Dengue%20Vaccine,DENV%20serotypes%20(Figure%201A). |
| Última Modificación | 4 Dec 202304/12/23 at 09:442023-12-04 09:44:04 |
| Control Dinámico de Carga Académica | |
| Dedicación Estimada | 40m |